Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Magenta Therapeutics Inc. (curative stem cell transplantation) raised $50mm through an oversubscribed Series B round from GV (lead; formerly Google Ventures) and all existing investors including Atlas Venture, Third Rock Ventures, Partners Innovation Fund, Access Industries, Casdin Capital, Be The Match BioTherapies, and undisclosed crossover investors. The company also announced an in-licensing from Novartis AG, and a partnership with Be The Match BioTherapies, a division of bone marrow and umbilical cord transplantation organization National Marrow Donor Program/Be The Match.
Gene Therapy, Cell Therapy
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?